L'équipe du département de pharmacologie






Université Bordeaux 2 CHU de Bordeaux INSERM
Département Hospitalo-Universitaire de Pharmacologie de Bordeaux
  • Home
  • Publications in 2018


Publications' last update : 2020-02-25

  1. Risk of Serious Trauma with Glucose-Lowering Drugs in Older Persons: A Nested Case-Control Study
    J Am Geriatr Soc. 2018 (66-11) 2086-2091
    Arnaud M, Pariente A, Bezin J, Bégaud B, Salvo F.
     PubMed citation

  2. [From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)]
    Therapie. 2018 (ahead of print)
    Baumevieille M, Perri-Plandé J, Miremont-Salamé G, Daveluy A, Haramburu F.
     PubMed citation

  3. [Will be 60 years the age of reason?]
    Presse Med. 2018 (47-10) 870-871
    Bégaud B.
     PubMed citation

  4. A history of pharmacoepidemiology
    Therapie. 2018 (74-2) 175-179
    Bégaud B.
     PubMed citation

  5. Monitoring of drug misuse or potential misuse in a nationwide healthcare insurance database: A cross-sectional study in France
    Therapie. 2018 (74-4) 469-476
    Bénard-Laribière A, Noize P, Girodet PO, Lassalle R, Dureau-Pournin C, Droz-Perroteau C, Fourrier-Réglat A, Salvo F, Bezin J, Pariente A; DRUGS-2M study group.
     PubMed citation

  6. Patterns of antidepressant use during pregnancy: a nationwide population-based cohort study
    Br J Clin Pharmacol. 2018 (84-8) 1764-1775
    Bénard-Laribière A, Pambrun E, Sutter-Dallay AL, Gautier S, Hurault-Delarue C, Damase-Michel C, Lacroix I, Bégaud B, Pariente A.
     PubMed citation

  7. [Benzodiazepine use and misuse in France]
    Presse Med. 2018 (47-10) 878-881
    Bénard-Laribière A, Pariente A.
     PubMed citation

  8. Reply to 'The easy misuse of antidepressants during pregnancy is depressing'
    Br J Clin Pharmacol. 2018 (84-10) 2447-2448
    Bénard-Laribière A, Sutter-Dallay AL, Pariente A.
     PubMed citation

  9. Use of lipid-lowering drugs and the risk of cataract: a population-based nested case-control study
    Clin Pharmacol Ther. 2018 (105-2) 458-465
    Bezin J, Mansiaux Y, Noize P, Salvo F, Bégaud B, Pariente A.
     PubMed citation

  10. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database
    CNS Drugs. 2018 (32-7) 673-684
    Billioti de Gage S, Collin C, Le-Tri T, Pariente A, Bégaud B, Verdoux H, Dray-Spira R, Zureik M.
     PubMed citation

  11. An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
    Allergy Asthma Clin Immunol. 2018 (14) 38
    Blin P, Demoly P, Drouet M, Falissard B, Lignot-Maleyran S, Maizi H, Lorrain S, Lassalle R, Droz-Perroteau C, Moore N, Molimard M.
     PubMed citation

  12. Secondary prevention of acute coronary events with antiplatelet agents (SPACE-AA): One-year real-world effectiveness and safety cohort study in the French nationwide claims database
    Atherosclerosis. 2018 (ahead of print)
    Blin P, Dureau-Pournin C, Benichou J, Bonello L, Dallongeville J, Danchin N, Falissard B, Thomas-Delecourt F, Jové J, Lassalle R, Droz C, Moore N.
     PubMed citation

  13. Effectiveness and safety of 110 or 150 mg dabigatran versus vitamin K antagonists in non-valvular atrial fibrillation
    Br J Clin Pharmacol. 2018 (ahead of print)
    Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.
     PubMed citation

  14. Comparative effectiveness and safety of standard or reduced dose dabigatran versus rivaroxaban in non-valvular atrial fibrillation
    Clin Pharmacol Ther. 2018 (ahead of print)
    Blin P, Dureau-Pournin C, Cottin Y, Bénichou J, Mismetti P, Abouelfath A, Lassalle R, Droz C, Moore N.
     PubMed citation

  15. Comparative effectiveness of direct oral anticoagulants versus low-molecular weight heparins for the prevention of venous thromboembolism after total hip or knee replacement: a nationwide database cohort study
    Pharmacol Res. 2018 (141) 201-207
    Blin P, Samama CM, Sautet A, Benichou J, Lignot-Maleyran S, Lamarque S, Lorrain S, Lassalle R, Droz-Perroteau C, Mismetti P, Moore N.
     PubMed citation

  16. Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database
    Pharmacoepidemiol Drug Saf. 2018 (ahead of print)
    Bosco-Lévy P, Duret S, Picard F, Dos Santos P, Puymirat E, Gilleron V, Blin P, Chatellier G, Looten V, Moore N.
     PubMed citation

  17. Breakthrough invasive aspergillosis and diagnostic accuracy of serum galactomannan enzyme immune assay during acute myeloid leukemia induction chemotherapy with posaconazole prophylaxis
    Oncotarget. 2018 (9-42) 26724-26736
    Calmettes C, Gabriel F, Blanchard E, Servant V, Bouchet S, Kabore N, Forcade E, Leroyer C, Bidet A, Latrabe V, Leguay T, Vigouroux S, Tabrizi R, Breilh D, Accoceberry I, de Lara MT, Pigneux A, Milpied N, Dumas PY.
     PubMed citation

  18. The Social Impact of Suspected Adverse Drug Reactions: An analysis of the Canada Vigilance Spontaneous Reporting Database
    Drug Saf. 2018 (42-1) 27-34
    Castillon G, Salvo F, Moride Y.
     PubMed citation

  19. Adverse drug reactions of analgesic medicines: analysis of the Romanian pharmacovigilance database
    Fundam Clin Pharmacol. 2018 (32-3) 330-336
    Cazacu I, Stroe R, Dondera R, Mogosan C, Haramburu F, Fourrier-Réglat A, Loghin F.
     PubMed citation

  20. Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case-case-control study
    J Antimicrob Chemother. 2018 (ahead of print)
    Coppry M, Jeanne-Leroyer C, Noize P, Dumartin C, Boyer A, Bertrand X, Dubois V, Rogues AM.
     PubMed citation

  21. Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting Database
    Front Pharmacol. 2018 (9) 1010
    Courtois É, Pariente A, Salvo F, Volatier É, Tubert-Bitter P, Ahmed I.
     PubMed citation

  22. [Psychoactive substances use in Réunion Island and Mayotte, French departments in Indian Ocean]
    Therapie. 2018 (73-5) 419-427
    Daveluy A, Haramburu F.
     PubMed citation

  23. Tamper-resistant prescription forms for narcotics in France: should we generalise them?
    Fundam Clin Pharmacol. 2018 (32-5) 571-577
    Daveluy A, Sauvaget L, Bastien A, Lapeyre-Mestre M, Collin C, Richard N, Haramburu F.
     PubMed citation

  24. Rhabdomyolysis after co-administration of a statin and fusidic acid: an analysis of the literature and of the WHO database of adverse drug reactions
    Br J Clin Pharmacol. 2018 (84-5) 1057-1063
    Deljehier T, Pariente A, Miremont-Salamé G, Haramburu F, Nguyen L, Rubin S, Rigothier C, Théophile H.
     PubMed citation

  25. Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: a retrospective database study in France
    Allergy. 2018 (ahead of print)
    Devillier P, Molimard M, Ansolabehere X, Bardoulat I, Coulombel N, Maurel F, Le Jeunne P, Demoly P.
     PubMed citation

  26. Biomonitoring of occupational exposure to 5-FU by assaying ?-fluoro-?-alanine in urine with a highly sensitive UHPLC-MS/MS method
    Analyst. 2018 (143-17) 4110-4117
    Dhersin A, Atgé B, Martinez B, Titier K, Rousset M, Sidatt Cheikh El Moustaph M, Verdun-Esquer C, Molimard M, Villa A, Canal-Raffin M.
     PubMed citation

  27. Coronary Events After Dispensing of Ibuprofen: A Propensity Score-Matched Cohort Study Versus Paracetamol in the French Nationwide Claims Database Sample
    Drug Saf. 2018 (41-11) 1049-1058
    Duong M, Abouelfath A, Lassalle R, Droz C, Blin P, Moore N.
     PubMed citation

  28. The economic burden of preventable adverse drug reactions: a systematic review of observational studies
    Expert Opin Drug Saf. 2018 (17-7) 681-695
    Formica D, Sultana J, Cutroneo PM, Lucchesi S, Angelica R, Crisafulli S, Ingrasciotta Y, Salvo F, Spina E, Trifirò G.
     PubMed citation

  29. Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study
    Clin Colorectal Cancer. 2018 (18-1) e150-e162
    Gouverneur A, Coutureau J, Jové J, Rouyer M, Grelaud A, Duc S, Gérard S, Smith D, Ravaud A, Droz C, Bernard MA, Lassalle R, Forrier-Réglat A, Noize P; ETNA study group and the EREBUS study group.
     PubMed citation

  30. Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic review
    J Geriatr Oncol. 2018 (9-1) 15-23
    Gouverneur A, Salvo F, Berdaï D, Moore N, Fourrier-Réglat A, Noize P.
     PubMed citation

  31. Increased long QT and torsade de pointes reporting on tamoxifen compared with aromatase inhibitors
    Heart. 2018 (104-22) 1859-1863
    Grouthier V, Lebrun-Vignes B, Glazer AM, Touraine P, Funck-Brentano C, Pariente A, Courtillot C, Bachelot A, Roden DM, Moslehi JJ, Salem JE.
     PubMed citation

  32. Risk of hospital admission for liver injury in users of NSAIDs and nonoverdose paracetamol: Preliminary results from the EPIHAM study
    Pharmacoepidemiol Drug Saf. 2018 (27-11) 1174-1181
    Gulmez SE, Unal US, Lassalle R, Chartier A, Grolleau A, Moore N.
     PubMed citation

  33. Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
    Eur Respir J. 2018 (51) 1702523
    Humbert M, Taillé C, Mala L, Le Gros V, Just J, Molimard M.
     PubMed citation

  34. Antidepressants during pregnancy: a French drug utilisation study in EFEMERIS cohort
    Eur Arch Psychiatry Clin Neurosci. 2018 (269-7) 841-849
    Hurault-Delarue C, Lacroix I, Bénard-Laribière A, Montastruc JL, Pariente A, Damase-Michel C.
     PubMed citation

  35. Systematic review of association between critical errors in inhalation and health outcomes in asthma and COPD
    NPJ Prim Care Respir Med. 2018 (28-1) 43
    Kocks JWH, Chrystyn H, van der Palen J, Thomas M, Yates L, Landis SH, Driessen MT, Gokhale M, Sharma R, Molimard M.
     PubMed citation

  36. Impact of cancer diagnosis on persistence of oral antidiabetic drugs
    Diabetes Res Clin Pract. 2018 (139) 323-330
    Létinier L, Mansiaux Y, Pariente A, Fourrier-Réglat A.
     PubMed citation

  37. Baseline results from the European non-interventional Antipsychotic Long acTing injection in schizOphrenia (ALTO) study
    Eur Psychiatry. 2018 (52) 85-94
    Llorca PM, Bobes J, Fleischhacker WW, Heres S, Moore N, Bent-Ennakhil N, Sapin C, Loze JY, Nylander AG, Patel MX.
     PubMed citation

  38. Non-communicable diseases in Indian slums: re-framing the Social Determinants of Health
    Glob Health Action. 2018 (11-1)
    Lumagbas LB, Coleman HLS, Bunders J, Pariente A, Belonje A, de Cock Buning T.
     PubMed citation

  39. Non-bleeding Adverse Events with the Use of Direct Oral Anticoagulants: A Sequence Symmetry Analysis
    Drug Saf. 2018 (41-9) 881-897
    Maura G, Billionnet C, Coste J, Weill A, Neumann A, Pariente A.
     PubMed citation

  40. High throughput routine determination of 17 tyrosine kinase inhibitors by LC-MS/MS
    J Pharm Biomed Anal. 2018 (150) 112-120
    Merienne C, Rousset M, Ducint D, Castaing N, Titier K, Molimard M, Bouchet S.
     PubMed citation

  41. Inhaled triple therapy in chronic obstructive pulmonary disease
    Lancet. 2018 (392-10153) 1112
    Molimard M, Girodet PO, Moore N.
     PubMed citation

  42. Interest of pharmacoepidemiology for the study of inhaled drugs
    Therapie. 2018 (ahead of print)
    Molimard M, Girodet PO, Van Ganse E.
     PubMed citation

  43. Antipsychotics use: 2006-2013 trends in prevalence and incidence and characterization of users
    Eur J Clin Pharmacol. 2018 (74-5) 619-626
    Montastruc F, Bénard-Laribière A, Noize P, Pambrun E, Diaz-Bazin F, Tournier M, Bégaud B, Pariente A.
     PubMed citation

  44. Atropinic (Anticholinergic) Burden in Antipsychotic-Treated Patients
    Fundam Clin Pharmacol. 2018 (32-1) 114-119
    Montastruc F, Benevent J, Touafchia A, Chebane L, Araujo M, Guitton-Bondon E, Durrieu G, Arbus C, Schmitt L, Bé gaud B, Montastruc JL.
     PubMed citation

  45. Pharmacoepidemiology of non-steroidal anti-inflammatory drugs
    Therapie. 2018 (74-2) 271-277
    Moore N, Duong M, Gulmez SE, Blin P, Droz C.
     PubMed citation

  46. Previous Drug Exposure in Patients Hospitalised for Acute Liver Injury: A Case-Population Study in the French National Healthcare Data System.
    Drug Saf. 2018 (42-4) 559-572
    Moore N, Duret S, Grolleau A, Lassalle R, Barbet V, Duong M, Thurin N, Droz-Perroteau C, Gulmez SE.
     PubMed citation

  47. Gastrointestinal safety and tolerability of oral non-aspirin over-the-counter analgesics
    Postgrad Med. 2018 (130-2) 188-199
    Moore N, Scheiman JM.
     PubMed citation

  48. Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database
    Drug Saf. 2018 (41-8) 767-774
    Mouchet J, Bégaud B.
     PubMed citation

  49. Authors' Reply to Cohen et al.'s Comment on "Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database"
    Drug Saf. 2018 (41-12) 1429-1430
    Mouchet J, Bégaud B.
     PubMed citation

  50. Hepatitis B vaccination and the putative risk of central demyelinating diseases - A systematic review and meta-analysis
    Vaccine. 2018 (36-12) 1548-1555
    Mouchet J, Salvo F, Raschi E, Poluzzi E, Antonazzo IC, De Ponti F, Bégaud B.
     PubMed citation

  51. Human papillomavirus vaccine and demyelinating diseases-A systematic review and meta-analysis
    Pharmacol Res. 2018 (132) 108-118
    Mouchet J, Salvo F, Raschi E, Poluzzi E, Antonazzo IC, De Ponti F, Bégaud B.
     PubMed citation

  52. [The nocebo effect: Various aspects and consequences in clinical practice]
    Rev Med Interne. 2018 (39-5) 315-320
    Mouly S, Bergmann JF, Molimard M.
     PubMed citation

  53. Assessment of the state of pharmacovigilance in the South-South zone of Nigeria using WHO pharmacovigilance indicators
    BMC Pharmacol Toxicol. 2018 (19-1) 27
    Opadeyi AO, Fourrier-Réglat A, Isah AO.
     PubMed citation

  54. [Use and misuse of benzodiazepines in patients with psychiatric disorders]
    Presse Med. 2018 (47-10) 886-891
    Panes A, Fourrier-Réglat A, Verdoux H, Tournier M.
     PubMed citation

  55. Use of benzodiazepines and z-drugs not compliant with guidelines and associated factors: a population-based study
    Eur Arch Psychiatry Clin Neurosci. 2018 (ahead of print)
    Panes A, Pariente A, Bénard-Laribière A, Lassalle R, Dureau-Pournin C, Lorrain S, Tournier M, Fourrier-Réglat A.
     PubMed citation

  56. Detection of drug safety signals from clinical trials data: Role of SUSARs
    Pharmacol Res. 2018 (131) 218-223
    Perez C, Olivier P, Lortal B, Duranton S, Montastruc JL, Colin AL, Toulza E, Becker M, Hamy L, Crepin S, Roussillon C, Gimbert A, Petitpain N, Salvo F.
     PubMed citation

  57. children: A pilot study
    Environ Res. 2018 (169) 189-195
    Raherison C, Baldi I, Pouquet M, Berteaud E, Moesch C, Bouvier G, Canal-Raffin M.
     PubMed citation

  58. Comorbidities and COPD severity in a clinic-based cohort
    BMC Pulm Med. 2018 (18-1) 117
    Raherison C, Ouaalaya EH, Bernady A, Casteigt J, Nocent-Eijnani C, Falque L, Le Guillou F, Nguyen L, Ozier A, Molimard M.
     PubMed citation

  59. Trends in attention-deficit hyperactivity disorder medication use: a retrospective observational study using population-based databases
    Lancet Psychiatry. 2018 (5-10) 824-835
    Raman SR, Man KKC, Bahmanyar S, Berard A, Bilder S, Boukhris T, Bushnell G, Crystal S, Furu K, KaoYang YH, Karlstad Ø, Kieler H, Kubota K, Lai EC, Martikainen JE, Maura G, Moore N, Montero D, Nakamura H, Neumann A, Pate V, Pottegård A, Pratt NL, Roughead EE, Macias Saint-Gerons D, Stürmer T, Su CC, Zoega H, Sturkenbroom MCJM, Chan EW, Coghill D, Ip P, Wong ICK.
     PubMed citation

  60. Pharmacovigilance of sodium-glucose co-transporter-2 inhibitors: What a clinician should know on disproportionality analysis of spontaneous reporting systems
    Nutr Metab Cardiovasc Dis. 2018 (28-6) 533-542
    Raschi E, Poluzzi E, Salvo F, Pariente A, De Ponti F, Marchesini G, Moretti U.
     PubMed citation

  61. Effectiveness of Cetuximab as First-Line Therapy for Patients With Wild-Type KRAS and Unresectable Metastatic Colorectal Cancer in Real-Life Practice: Results of the EREBUS Cohort
    Clin Colorectal Cancer. 2018 (17-2) 129-139
    Rouyer M, François E, Cunha AS, Monnereau A, Noize P, Robinson P, Droz-Perroteau C, Le Monies de Sagazan A, Jové J, Lassalle R, Moore N, Fourrier-Réglat A, Smith D; EREBUS Study Group.
     PubMed citation

  62. Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study
    Lancet Oncol. 2018 (19-12) 1579-1589
    Salem JE, Manouchehri A, Moey M, Lebrun-Vignes B, Bastarache L, Pariente A, Gobert A, Spano JP, Balko JM, Bonaca MP, Roden DM, Johnson DB, Moslehi JJ.
     PubMed citation

  63. Interest and challenges of pharmacoepidemiology for the study of drugs used in diabetes
    Therapie. 2018 (74-2) 255-260
    Salvo F, Faillie JL.
     PubMed citation

  64. [Understanding the distrust towards the assessment of medicines. Beyond conflict of interests]
    Therapie. 2018 (73-4) 341-348
    Tournay V, Pariente A.
     PubMed citation

  65. [Use and misuse of benzodiazepines out of France]
    Presse Med. 2018 (47-10) 882-885
    Tournier M, Pariente A, Bégaud B, Bénard-Laribière A.
     PubMed citation

  66. [Should the duration of treatment be limited using benzodiazepines?]
    Presse Med. 2018 (47-10) 892-898
    Vorspan F, Barré T, Pariente A, Montastruc F, Tournier M.
     PubMed citation

  67. Anticholinergic drug use and cognitive performances in middle age: findings from the CONSTANCES cohort
    J Neurol Neurosurg Psychiatry. 2018 (89-10) 1107-1115
    Ziad A, Olekhnovitch R, Ruiz F, Berr C, Bégaud B, Goldberg M, Zins M, Mura T.
     PubMed citation